RT Journal Article
SR Electronic
T1 A semi-parametric, state-space compartmental model with time-dependent parameters for forecasting COVID-19 cases, hospitalizations, and deaths
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.02.21262995
DO 10.1101/2021.09.02.21262995
A1 O’Dea, Eamon B.
A1 Drake, John M.
YR 2021
UL http://medrxiv.org/content/early/2021/12/06/2021.09.02.21262995.abstract
AB Short-term forecasts of the dynamics of COVID-19 in the period up to its decline following mass vaccination was a task that received much attention but proved difficult to do with high accuracy. However, the availability of standardized forecasts and versioned data sets from this period allows for continued work in this area. Here we introduce the Gaussian Infection State Space with Time-dependence (GISST) forecasting model. We evaluate its performance in 1-4 week ahead forecasts of COVID-19 cases, hospital admissions, and deaths in the state of California made with official reports of COVID-19, Google’s mobility reports, and vaccination data available each week. Evaluation of these forecasts with a weighted interval score shows them to consistently outperform a naive baseline forecast and often score closer to or better than a high-performing ensemble forecaster. The GISST model also provides parameter estimates for a compartmental model of COVID-19 dynamics, includes a regression submodel for the transmission rate, and allows for parameters to vary over time according to a random walk. GISST provides a novel, balanced combination of computational efficiency, model interpretability, and applicability to large multivariate data sets that may prove useful in improving the accuracy of infectious disease forecasts.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJMD received grant NSF DEB-2027786 from the National Science Foundation (nsf.org).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Analysis was limited to highly aggregated data and therefore no oversight was required.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are publicly available at sources cited in the main text and all relevant code is publicly available online. https://doi.org/10.5281/zenodo.5112578